Table 2.
Comparison of differences between and within groups after a 12-week training program. Data are expressed as means ± SD
| Group/characteristics | Post Test | p-value within groups | p-value between groups | ||
|---|---|---|---|---|---|
| Control | Experimental | Control | Experimental | ||
| Weight (kg) | 80.54 ±5.06 | 75.25 ±5.67 | 0.15 | < 0.001 | 0.05 |
| Body mass index (BMI) (kg/m2) | 30.88 ±1.26 | 28.64 ±1.37 | 0.13 | < 0.001 | 0.04 |
| Waist circumference (WC) (cm) | 93.08 ±7.07 | 88.62 ±6.48 | 0.34 | < 0.001 | 0.05 |
| Waist to hip ratio | 0.88 ±0.02 | 0.84 ±0.02 | 0.17 | < 0.001 | 0.01 |
| Fat (%) | 33.58 ±2.60 | 29.46 ±1.48 | 0.33 | < 0.001 | 0.05 |
| Serum fasting glucose (mmol/l) | 5.83 ±0.21 | 5.27 ±0.17 | 0.56 | < 0.001 | 0.002 |
| Serum fasting insulin (μU/ml) | 13.42 ±2.07 | 10.62 ±2.28 | 0.45 | < 0.001 | 0.05 |
| HOMA-IR | 3.48 ±0.55 | 2.49 ±0.53 | 0.96 | < 0.001 | 0.05 |
| TNF-α (pg/ml) | 6.13 ±1.39 | 3.10 ±1.91 | 0.41 | < 0.001 | 0.05 |
| sTNF-R1 (ng/ml) | 2.87 ±0.81 | 1.69 ±0.71 | 0.37 | < 0.001 | 0.05 |
| sTNF-R2 (ng/ml) | 5.51 ±0.50 | 4.27 ±0.58 | 0.31 | < 0.001 | 0.01 |
| CXCL5 (pg/ml) | 2765.3 ±315.3 | 2290.2 ±345.9 | 0.06 | < 0.001 | 0.05 |